BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17703937)

  • 1. The role of ThinPrep cytology in the investigation of SLN status in patients with cutaneous melanoma.
    Papadopoulos O; Konofaos P; Georgoulakis J; Chrisostomidis C; Tsantoulas Z; Kostopoulos E; Stratigos A; Karipidis D; Karakitsos P
    Surg Oncol; 2007 Aug; 16(2):121-9. PubMed ID: 17703937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology.
    Creager AJ; Shiver SA; Shen P; Geisinger KR; Levine EA
    Cancer; 2002 Jun; 94(11):3016-22. PubMed ID: 12115392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Feasibility and technical problems of sentinel node analysis in melanoma].
    Mebazaa A; Kerob D; Toubert ME; Verola O; Servant JM; Baccard M; Billotey C; Bustamante K; Vandici FO; Basset-Seguin N; Ollivaud L; Morel P; Lebbé C
    Ann Chir Plast Esthet; 2007 Feb; 52(1):14-23. PubMed ID: 17141391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
    Rossi CR; De Salvo GL; Bonandini E; Mocellin S; Foletto M; Pasquali S; Pilati P; Lise M; Nitti D; Rizzo E; Montesco MC
    Ann Surg Oncol; 2008 Apr; 15(4):1202-10. PubMed ID: 18165880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node status in melanoma: a valuable prognostic factor?
    Topar G; Eisendle K; Zelger B; Fritsch P
    Br J Dermatol; 2006 Jun; 154(6):1080-7. PubMed ID: 16704637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative touch imprint cytological analysis of sentinel lymph nodes for the presence of metastases in malignant melanoma.
    Tamiolakis D; Venizelos J; Jivanakis T; Antoniou C; Economou C; Tsiminikakis N; Georgiou G; Alexiadis G; Costopoulou A
    Minerva Med; 2008 Feb; 99(1):15-21. PubMed ID: 18299693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa.
    Ho VH; Ross MI; Prieto VG; Khaleeq A; Kim S; Esmaeli B
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):820-6. PubMed ID: 17709624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy as guidance for central neck dissection in patients with papillary thyroid carcinoma.
    Roh JL; Park CI
    Cancer; 2008 Oct; 113(7):1527-31. PubMed ID: 18671238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy.
    Morris KT; Busam KJ; Bero S; Patel A; Brady MS
    Ann Surg Oncol; 2008 Jan; 15(1):316-22. PubMed ID: 18004626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.
    Kesmodel SB; Karakousis GC; Botbyl JD; Canter RJ; Lewis RT; Wahl PM; Terhune KP; Alavi A; Elder DE; Ming ME; Guerry D; Gimotty PA; Fraker DL; Czerniecki BJ; Spitz FR
    Ann Surg Oncol; 2005 Jun; 12(6):449-58. PubMed ID: 15864482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
    Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
    Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
    Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
    Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of metallothionein-overexpression with sentinel lymph node biopsy as prognostic factors in melanoma.
    Weinlich G; Topar G; Eisendle K; Fritsch PO; Zelger B
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):669-77. PubMed ID: 17447982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI).
    Testori A; De Salvo GL; Montesco MC; Trifirò G; Mocellin S; Landi G; Macripò G; Carcoforo P; Ricotti G; Giudice G; Picciotto F; Donner D; Di Filippo F; Soteldo J; Casara D; Schiavon M; Vecchiato A; Pasquali S; Baldini F; Mazzarol G; Rossi CR;
    Ann Surg Oncol; 2009 Jul; 16(7):2018-27. PubMed ID: 19132446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional recurrence after negative sentinel lymph node biopsy for melanoma.
    Carlson GW; Page AJ; Cohen C; Parker D; Yaar R; Li A; Hestley A; Delman KA; Murray DR
    Ann Surg; 2008 Sep; 248(3):378-86. PubMed ID: 18791358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasonography and fine-needle aspiration cytology in the preoperative evaluation of melanoma patients eligible for sentinel node biopsy.
    van Rijk MC; Teertstra HJ; Peterse JL; Nieweg OE; Olmos RA; Hoefnagel CA; Kroon BB
    Ann Surg Oncol; 2006 Nov; 13(11):1511-6. PubMed ID: 17009151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients with melanoma and histologically negative sentinel lymph nodes: one institution's experience.
    De Giorgi V; Leporatti G; Massi D; Lo Russo G; Sestini S; Dini M; Lotti T
    Oncology; 2007; 73(5-6):401-6. PubMed ID: 18515980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.